The present analysis aims to evaluate the consequences of a 2-month interruption of mammographic screening on breast cancer (BC) stage at diagnosis and upfront treatments in a region of Northern Italy highly affected by the severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) virus.
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era / Toss, A; Isca, C; Venturelli, M; Nasso, C; Ficarra, G; Bellelli, V; Armocida, C; Barbieri, E; Cortesi, L; Moscetti, L; Piacentini, F; Omarini, C; Andreotti, A; Gambini, A; Battista, R; Dominici, M; Tazzioli, G. - In: ESMO OPEN. - ISSN 2059-7029. - 6:2(2021), pp. 1-6. [10.1016/j.esmoop.2021.100055]
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
Toss, A
Writing – Review & Editing
;Isca, CMembro del Collaboration Group
;Nasso, CMembro del Collaboration Group
;Piacentini, FMembro del Collaboration Group
;Omarini, C;Dominici, MMembro del Collaboration Group
;Tazzioli, GSupervision
2021
Abstract
The present analysis aims to evaluate the consequences of a 2-month interruption of mammographic screening on breast cancer (BC) stage at diagnosis and upfront treatments in a region of Northern Italy highly affected by the severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) virus.
| File | Dimensione | Formato | |
|---|---|---|---|
|
TOSS 2021.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
340.79 kB
Formato
Adobe PDF
|
340.79 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
